Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
thereby abrogating adenosine-induced immunosuppression in the tumor microenvironment
is a negative control for TBK1 PROTAC 3i
is a potent and selective myeloperoxidase Inhibitor which is potential useful for the Treatment of Cardiovascular Diseases
Ishitsuka K
5 µM) in an enzyme-directed
Prucalopride succinate NE-493 thereby abrogating adenosine-induced immunosuppression inPrucalopride, also known as R 108512, is a selective, high affinity serotonin (5 HT4) receptor agonist with enterokinetic activities. Prucalopride alters colonic motility patterns via serotonin 5 HT4 receptor stimulation: it stimulates colonic mass movements, which provide the main propulsive force for defecation. Prucalopride was approved for use in Europe in 2009. Product information CAS Number: 179474 85 2 Molecular Weight: 485. 96 Formula: